5:01 Acquisition Corp. (FVAM)
Stock Price:
$10.10 USD
0.10 (1.00%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
104.64M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-993 |
| Shares Out |
10.36M |
| EPS (ttm) |
0.00 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 21, 2020 |
| Last Price |
$10.10 |
| Previous Close |
$10.00 |
| Change ($) |
0.10 |
| Change (%) |
1.00% |
| Day's Open |
10.10 |
| Day's Range |
10.00 - 10.20 |
| Day's Volume |
68,328 |
| 52-Week Range |
9.98 - 11.00 |
More Stats
| Market Cap |
104.64M |
| Enterprise Value |
n/a |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
10.36M |
| Float |
n/a |
| EPS (basic) |
n/a |
| EPS (diluted) |
0.00 |
| FCF / Share |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
n/a |
| Revenue |
n/a |
| Operating Income |
n/a |
| Net Income |
-993 |
| Free Cash Flow |
n/a |
| Net Cash |
n/a |
| Net Cash / Share |
n/a |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Overview
No financial data available for this stock yet.
Company Details
| Full Name |
5:01 Acquisition Corp. |
| Country |
United States |
| CEO |
Kush M. Parmar |
Stock Information
| Ticker Symbol |
FVAM |
| Stock Exchange |
NASDAQ |
| Sector |
Financial Services |
| Industry |
Shell Companies |
| Unique Identifier |
NASDAQ: FVAM |
| IPO Date |
October 14, 2020 |
Description
5:01 Acquisition is a newly organized blank check company incorporated in August 2020 as a Delaware corporation whose primary business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to initially focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business. In particular, we intend to target early stage North American or European companies in the biotechnology sector of the healthcare industry where our management has extensive investment and operational experience. We may also pursue a transaction in which our stockholders immediately prior to the completion of our initial business combination would collectively own a minority interest in the post-business combination company.